loadpatents
Patent applications and USPTO patent grants for Thompson; Andrea Y..The latest application filed is for "cross-linked polysaccharide drug carrier".
Patent | Date |
---|---|
Cross-linked polysaccharide drug carrier Grant 6,953,784 - Thompson , et al. October 11, 2 | 2005-10-11 |
Cross-linked polysaccharide drug carrier App 20040077592 - Thompson, Andrea Y. ;   et al. | 2004-04-22 |
Cross-linked polysaccharide drug carrier Grant 6,683,064 - Thompson , et al. January 27, 2 | 2004-01-27 |
Cross-linked polysaccharide drug carrier App 20030012765 - Thompson, Andrea Y. ;   et al. | 2003-01-16 |
Cross-linked polysaccharide drug carrier Grant 6,303,585 - Spiro , et al. October 16, 2 | 2001-10-16 |
Method and activin compositions for inducing bone growth Grant 5,413,989 - Ogawa , et al. * May 9, 1 | 1995-05-09 |
Use of bone morphogenetic protein in synergistic combination with TGF-.beta. for bone repair Grant 5,393,739 - Bentz , et al. February 28, 1 | 1995-02-28 |
Method for inducing bone growth Grant 5,208,219 - Ogawa , et al. May 4, 1 | 1993-05-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.